Home LiteratureArticle Details
PMID: 10942328 Published · ppublish English Journal Article

Lung cancer treatment waiting times and tumour growth.

Clinical oncology (Royal College of Radiologists (Great Britain)) ·Vol. 12 ·No. 3 ·2000-00-00 ·Pages 141-4

O'Rourke N, Edwards R

Abstract

We report a single-centre prospective audit of 29 lung cancer patients who were awaiting radical (potentially curative) radiotherapy. This was the total number assessed as suitable for radical treatment by one consultant during 1999. At the time of assessment they had been newly diagnosed and staged with a computed tomographic (CT) scan of chest. They had a subsequent CT scan prior to starting treatment for the purpose of planning the radiation fields. We have now measured tumour size on the diagnostic scans and compared this with the size on the planning scans. We have documented the delay between diagnostic and planning CT scanning and the total time between first hospital visit and starting treatment. Two patients had progression of symptoms while on the waiting list, making them unfit for radical treatment, and another four had tumour progression on planning CT such that the tumour volume was too large for radical treatment. Therefore, 21% of potentially curable patients became incurable on the waiting list. The delay between diagnostic and planning CT scans ranged from 18 to 131 days (median 54), with increases in the cross-sectional tumour size over that period ranging zero to 373%. The delay between the first hospital visit and starting treatment was 35-187 days (median 94); between the date of the radiotherapy request and the starting date for treatment it was 23-61 days (median 44). Limited access to specialists is the reason most often advanced for the poor performance of the UK in treating lung cancer. This study demonstrates that, even for the select minority of patients who have specialist referral and are deemed suitable for potentially curative treatment, the outcome is prejudiced by waiting times that allow tumour progression.

MeSH Terms
Aged Carcinoma, Non-Small-Cell Lung/diagnosis,pathology,radiotherapy Female Humans Lung Neoplasms/diagnosis,pathology,radiotherapy Male Middle Aged Prospective Studies Time Factors Tomography, X-Ray Computed United Kingdom Waiting Lists
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
O'Rourke N
Beatson Oncology Centre, Western Infirmary, Glasgow, UK. norourke@tinyworld.co.uk
Edwards R
Article Info
Journal
Clinical oncology (Royal College of Radiologists (Great Britain))
Abbr.
Clin Oncol (R Coll Radiol)
ISSN
0936-6555
Published
2000-00-00
Pages
141-4
Language
English
Region
England
NLM ID
9002902
Subset
IM
Corrections
CommentIn
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com